The present invention relates to a composition comprising at least one GnRH antagonist and wherein the composition is arranged for being administered in two different administration routes, thereby providing an enhanced bioavailability. Said composition may be used for treating or preventing a disease or condition related to the release of a gonadotropin hormone.
